Pharma Focus Asia

Pharma Press Releases

Keep up to date with the latest technological developments happening across the Pharmaceutical industry. Our press releases can help you boost your online reach and exposure worldwide. Our Press releases provides information on the latest research in pharma.

Baker McKenzie advises Prenetics on USD 200 million joint venture with globally renowned scientist Professor Dennis Lo

Thursday, June 29, 2023

Hong Kong SAR China June Baker McKenzie is advising Prenetics Global Limited Prenetics a leading genomicsdriven health sciences company listed on Nasdaq on the creation of a USD million joint venture named Insighta with globally renowned scientis...

Clarity establishes a US Center of Excellence for Targeted Copper Theranostics

Friday, June 30, 2023

Clarity Pharmaceuticals ASX CU Clarity a clinicalstage radiopharmaceutical company with a mission to develop nextgeneration products that improve treatment outcomes for children and adults with cancer is pleased to announce the establishment of a Cen...

Drug Farm Announces IND Clearance by U.S. FDA Enabling Phase 1 Initiation for First-in-Class Oral ALPK1 Selective Kinase Inhibitor, DF-003

Friday, June 30, 2023

Drug Farm announced today the US Food and Drug Administration FDA has cleared the Investigational New Drug IND application of DF a firstinclass oral potent highly selective ALPK inhibitor for clinical evaluation

Merck Invests Approximately € 70 Million to Expand Reagent Manufacturing in China

Friday, June 30, 2023

Merck a leading science and technology company is expanding production capacity for highlypurified reagents at its site in Nantong China a major transportation hub in the Yangtze River Delta region The approximate million investment will allow the...

Jacobio Pharma Presents Clinical Results of Glecirasib in Colorectal Cancer

Friday, June 30, 2023

Beijing Kyoto Boston Jun Jacobio Pharma HK a clinicalstage oncology company drugging the undruggable targets today announced clinical results of its novel KRAS GC inhibitor glecirasib monotherapy and in combination therapy with cetuximab to treat...

Ambrosia Bio Leverages Ginkgo Enzyme Services to Develop a More Scalable Enzymatic Process for Allulose

Friday, June 30, 2023

Ambrosia Bio an Israeli foodtech company developing novel bioprocesses for the global sugar replacement industry and Ginkgo Bioworks NYSE DNA which is building the leading platform for cell programming and biosecurity today announced that Ambrosia Bi...

Microba Commences Phase I Clinical Trial for IBD Therapeutic

Thursday, June 29, 2023

Microba Life Sciences Limited ASX MAP Microba or the Company today announced that the first participants have been successfully dosed in the Phase I Clinical Trial of MAP in Microbas Therapeutic Program in Inflammatory Bowel Disease IBD This milesto...

Sanyou Forms Partnership with Hangzhou Zhongmei Huadong Pharmaceutical, Catalyzing Innovative Drug Research and Development

Thursday, June 29, 2023

Recently Sanyou Biopharmaceuticals Co Ltd hereinafter referred to as Sanyou and Hangzhou Zhongmei Huadong Pharmaceutical Co Ltd a whollyowned subsidiary of Huadong Medicine Co Ltd SZ hereinafter referred to asHuadong Medicine signed a license agreeme...

Nuance Pharma's Partner Verona Pharma Submits New Drug Application to US FDA for Ensifentrine for the Maintenance Treatment of COPD

Thursday, June 29, 2023

Nuance Pharma announces its partner Verona Pharma plc Nasdaq VRNA has submitted a New Drug Application NDA to the US Food and Drug Administration FDA for approval of ensifentrine for the maintenance treatment of patients with chronic obstructive pul...

INova Pharmaceuticals Expands Consumer Healthcare Platform Through Business Acquisition

Tuesday, June 27, 2023

INova Pharmaceuticals is expanding its leading consumer healthcare platform through the acquisition of a portfolio of trusted wellknown consumer healthcare brands anchored by the iconic BETADINE product range